Ravi Madan/X
Aug 5, 2025, 11:31
Ravi A Madan: When Seeing More Is Detrimental to Care
Ravi A Madan, Clinical researcher at the National Cancer Institute, shared a post on X about a paper he co-authored with colleagues published in Journal of Clinical Oncology.
“Restaging with PSMA Imaging in mCRPC Prostate Cancer: When Seeing More Is Detrimental to Care
Sadly a year later this remains true and the frequency of this is high.”
Title: Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care
Authors: Ravi A. Madan, Evan Y. Yu, Edwin M. Posadas, Richard J. Lee, Fatima Karzai, and Peter L. Choyke
Read The Full Article at Journal of Clinical Oncology.
More posts featuring Ravi A Madan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 26, 2025, 17:21
Aug 26, 2025, 17:15
Aug 26, 2025, 17:09
Aug 26, 2025, 16:36
Aug 26, 2025, 15:54